0

    543363

    PREVEST

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Prevest Denpro Limited Share Price Today

    Investment Returns

    Over 1 Month 2.32% Over 3 Months -9.25% Over 6 Months -15.87% Over 1 Year -27.38%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Prevest Denpro Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 468.00
    • P/E Ratio (TTM) 21.36
    • Beta 0.85
    • Book Value / share 104.82
    • Return on equity 18.74%
    • EPS (TTM) 17.84
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 6.06
    info icon alternate text

    Prevest Denpro Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 18.90
    Operating Expense 12.31
    Net Profit 6.06
    Net Profit Margin (%) 32.06
    Earnings Per Share (EPS) 5.05
    EBITDA 8.55
    Effective Tax Rate (%) 24.72
    Particulars DEC 2025 (Values in Cr)
    Revenue 18.37
    Operating Expense 12.66
    Net Profit 5.15
    Net Profit Margin (%) 28.03
    Earnings Per Share (EPS) 4.29
    EBITDA 7.38
    Effective Tax Rate (%) 25.03
    Particulars SEP 2025 (Values in Cr)
    Revenue 18.66
    Operating Expense 12.46
    Net Profit 5.57
    Net Profit Margin (%) 29.84
    Earnings Per Share (EPS) 4.64
    EBITDA 7.90
    Effective Tax Rate (%) 24.72
    Particulars JUN 2025 (Values in Cr)
    Revenue 15.72
    Operating Expense 10.68
    Net Profit 4.63
    Net Profit Margin (%) 29.45
    Earnings Per Share (EPS) 3.86
    EBITDA 6.70
    Effective Tax Rate (%) 25.44
    Particulars MAR 2025 (Values in Cr)
    Revenue 18.54
    Operating Expense 12.39
    Net Profit 5.25
    Net Profit Margin (%) 28.31
    Earnings Per Share (EPS) 4.37
    EBITDA 7.70
    Effective Tax Rate (%) 27.52
    Particulars MAR 2026 (Values in Cr)
    Revenue 71.66
    Operating Expense 48.12
    Net Profit 21.42
    Net Profit Margin (%) 29.89
    Earnings Per Share (EPS) 17.84
    EBITDA 30.52
    Effective Tax Rate (%) 24.94
    Particulars MAR 2025 (Values in Cr)
    Revenue 63.07
    Operating Expense 42.90
    Net Profit 18.20
    Net Profit Margin (%) 28.85
    Earnings Per Share (EPS) 15.16
    EBITDA 26.16
    Effective Tax Rate (%) 25.01
    Particulars MAR 2024 (Values in Cr)
    Revenue 56.44
    Operating Expense 37.89
    Net Profit 16.12
    Net Profit Margin (%) 28.56
    Earnings Per Share (EPS) 13.44
    EBITDA 22.69
    Effective Tax Rate (%) 24.70
    Particulars MAR 2023 (Values in Cr)
    Revenue 49.85
    Operating Expense 30.93
    Net Profit 15.71
    Net Profit Margin (%) 31.51
    Earnings Per Share (EPS) 13.09
    EBITDA 21.64
    Effective Tax Rate (%) 25.04
    Particulars MAR 2022 (Values in Cr)
    Revenue 38.11
    Operating Expense 23.68
    Net Profit 11.57
    Net Profit Margin (%) 30.35
    Earnings Per Share (EPS) 9.64
    EBITDA 16.67
    Effective Tax Rate (%) 27.91
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 87.95
    ROE % 18.70
    ROCE % 25.24
    Total Debt to Total Equity 0.00
    EBITDA Margin 40.66
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 73.83
    ROE % 18.21
    ROCE % 24.43
    Total Debt to Total Equity 0.00
    EBITDA Margin 39.18
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 87.98
    ROE % 18.74
    ROCE % 25.25
    Total Debt to Total Equity 0.00
    EBITDA Margin 40.65
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 73.82
    ROE % 19.98
    ROCE % 26.79
    Total Debt to Total Equity 0.00
    EBITDA Margin 39.14
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 60.65
    ROE % 24.19
    ROCE % 32.26
    Total Debt to Total Equity 0.01
    EBITDA Margin 43.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 47.56
    ROE % 29.08
    ROCE % 39.64
    Total Debt to Total Equity 0.03
    EBITDA Margin 42.80
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 789.33
    ROE % 38.14
    ROCE % 46.79
    Total Debt to Total Equity 0.08
    EBITDA Margin 34.68
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 60.89
    Total Assets 112.52
    Total Liabilities 112.52
    Total Equity 105.57
    Share Outstanding 1
    Price to Book Ratio 4.87
    Return on Assets (%) 16.13
    Return on Capital (%) 17.2
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 48.61
    Total Assets 94.81
    Total Liabilities 94.81
    Total Equity 88.61
    Share Outstanding 1
    Price to Book Ratio 4.78
    Return on Assets (%) 17.01
    Return on Capital (%) 18.21
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 60.46
    Total Assets 112.67
    Total Liabilities 112.67
    Total Equity 105.60
    Share Outstanding 1
    Price to Book Ratio 4.87
    Return on Assets (%) 16.15
    Return on Capital (%) 17.24
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 48.42
    Total Assets 94.81
    Total Liabilities 94.81
    Total Equity 88.60
    Share Outstanding 1
    Price to Book Ratio 4.78
    Return on Assets (%) 17.00
    Return on Capital (%) 18.2
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 39.00
    Total Assets 78.60
    Total Liabilities 78.60
    Total Equity 72.79
    Share Outstanding 1
    Price to Book Ratio 4.59
    Return on Assets (%) 19.98
    Return on Capital (%) 21.58
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 42.31
    Total Assets 64.14
    Total Liabilities 64.14
    Total Equity 57.08
    Share Outstanding 1
    Price to Book Ratio 7.59
    Return on Assets (%) 18.03
    Return on Capital (%) 19.79
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 16.42
    Total Assets 30.67
    Total Liabilities 30.67
    Total Equity 22.49
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 23.49
    Return on Capital (%) 30.17
    Particulars MAR 2025 (Values in Cr)
    Net Income 24.24
    Cash from Operations 20.86
    Cash from Investing -1.32
    Cash from Financing -1.20
    Net change in Cash 12.28
    Free Cash Flow 22.83
    Particulars MAR 2024 (Values in Cr)
    Net Income 21.43
    Cash from Operations 16.25
    Cash from Investing -1.70
    Cash from Financing -0.31
    Net change in Cash 9.60
    Free Cash Flow 19.98
    Particulars MAR 2025 (Values in Cr)
    Net Income 24.27
    Cash from Operations 21.00
    Cash from Investing -1.74
    Cash from Financing -1.20
    Net change in Cash 12.03
    Free Cash Flow 22.95
    Particulars MAR 2024 (Values in Cr)
    Net Income 21.41
    Cash from Operations 16.11
    Cash from Investing -1.75
    Cash from Financing -0.31
    Net change in Cash 9.42
    Free Cash Flow 19.84
    Particulars MAR 2023 (Values in Cr)
    Net Income 20.95
    Cash from Operations 15.59
    Cash from Investing -12.37
    Cash from Financing -1.36
    Net change in Cash -3.31
    Free Cash Flow 29.11
    Particulars MAR 2022 (Values in Cr)
    Net Income 16.05
    Cash from Operations 11.39
    Cash from Investing -3.86
    Cash from Financing 22.81
    Net change in Cash 25.91
    Free Cash Flow 16.28
    Particulars MAR 2021 (Values in Cr)
    Net Income 9.33
    Cash from Operations 10.65
    Cash from Investing -1.92
    Cash from Financing -0.56
    Net change in Cash 6.26
    Free Cash Flow 12.88
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 64.99 13.42 127127.92 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 51.48 23.29 2.81 96.48 40.75 76.00
    SHREE PACETRONIX LTD. 152.05 18.14 3.20 57.01 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.08 0.00 2.78 23.34 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8841.55 84.68 12.75 127127.92 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.61 0.00 -9.39 28.84 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5981.10 26.77 4.95 6543.32 5010.00 6725.00

    Prevest Denpro Limited shareholding pattern

    Holding
    24.97%
    73.6%
    0.64%
    0.76%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Prevest Denpro Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    389.90 2.29 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 384.60
    • 26 Days 386.60
    • 10 Days 384.60
    • 50 Days 393.60
    • 12 Days 384.60
    • 100 Days 410.20
    • 20 Days 385.40
    • 200 Days 440.80
    382.90 PIVOT
    First Support 378.25 First Resistance 385.80 Second Support 375.35 Second Resistance 390.45 Third Support 370.70 Third Resistance 393.35
    RSI 46.43 ADX 12.34 MACD -2.06 Williams % R -62.64 Commodity Channel Index (CCI) -34.03
    Date 2026-07-10 Week 6633.00 Same Day 6800.00 Month 4400.00
    1 Year 0.85 3 Year 0.90
    Over 1 Month
    2.32% down
    Over 1 Year
    -27.38% down
    Over 3 Months
    -9.25% down
    Over 3 Years
    -13.37% down
    Over 6 Months
    -15.87% down
    Over 5 Years
    14.99% down

    Prevest Denpro Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Sep 2025 1.0 Final 03 Sep 2025 Equity shares
    30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
    23 Aug 2023 1.0 Final 23 Aug 2023 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Prevest Denpro Ltd?

    Answer Field

    Prevest Denpro Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 389.90 as on Jul 13 2026 02:11 PM.

    What is the Market Cap of Prevest Denpro Ltd Share?

    Answer Field

    The market cap of Prevest Denpro Ltd for NSE ₹ 0.00 & for BSE ₹ 468.00 as on Jul 13 2026 02:11 PM.

    What is the 52 Week High and Low of Prevest Denpro Ltd?

    Answer Field

    The 52 Week High and Low of Prevest Denpro Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 622.05 and ₹ 318.15.

    What is 1 year return for Prevest Denpro Ltd?

    Answer Field

    The 1 year returns on the stock has been -27.38%.

    What is the P/E Ratio of Prevest Denpro Ltd Share?

    Answer Field

    As on Jul 13 2026 02:11 PM the price-to-earnings (PE) ratio for Prevest Denpro Ltd share is 21.36.

    What is the PB ratio of Prevest Denpro Ltd Share?

    Answer Field

    As on Jul 13 2026 02:11 PM, the price-to-book (PB) ratio for Prevest Denpro Ltd share is 104.82.

    How to Buy Prevest Denpro Ltd Share?

    Answer Field

    You can trade in Prevest Denpro Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Prevest Denpro Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Prevest Denpro Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Prevest Denpro Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |